Loading organization details...
Loading organization details...
THE ORGANIZATION IS DEVOTED TO CONTINUALLY IMPROVING THE HEALTH AND WELL-BEING OF THE PEOPLE AND COMMUNITIES THEY SERVE.
Source: IRS Form 990 (Tax Year 2024)
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2023
Total Revenue
▼$186.6M
Program Spending
90%
of total expenses go to program services
Total Contributions
$130K
Total Expenses
▼$194.3M
Total Assets
$67.1M
Total Liabilities
▼$275.8M
Net Assets
-$208.7M
Officer Compensation
→$6.8M
Other Salaries
$50.5M
Investment Income
$1.6M
Fundraising
▼$0
Tax Year 2023 · Source: IRS Form 990, Schedule I (Grants and Other Assistance)
Total grants awarded: $440.9K
| Recipient | Location | Amount | Type | Purpose |
|---|---|---|---|---|
CITY OF PROVIDENCE | PROVIDENCE, RI | $440.9K | Cash | GENERAL SUPPORT |
| Total | $440.9K | |||
CITY OF PROVIDENCE
PROVIDENCE, RI
$440.9K
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
-$3,584
VA/DoD Award Count
1
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding
$118.6M
Awards Found
111
Department of Health and Human Services
$3.4M
TAILORED LIFESTYLE INTERVENTION IN OBESE ADULTS WITHIN PRIMARY CARE PRACTICE
Department of Health and Human Services
$3.3M
TESTING THE EFFICACY OF A TECHNOLOGY-SUPPORTED LIFESTYLE PHYSICAL ACTIVITY INTERVENTION AMONG WOMEN WITH DEPRESSION IN ALCOHOL TREATMENT
Department of Health and Human Services
$3.1M
EVALUATION OF THE "COPING LONG TERM WITH ACTIVE SUICIDE PROGRAM"
Department of Health and Human Services
$3.1M
DEX/CRH RESPONSE: MOOD/ANXIETY DISORDER ENDOPHENOTYPE?
Department of Health and Human Services
$3M
INITIATING AND MAINTAINING PHYSICAL ACTIVITY IN DEPRESSED INDIVIDUALS
Department of Health and Human Services
$2.9M
PREDICTING SUICIDE: A LONGITUDINAL ANALYSIS OF SPEECH PATTERNS IN A HIGH RISK SAMPLE
Department of Health and Human Services
$2.8M
RISK PROFILES AND MECHANISMS OF DISEASE IN MALTREATED CHILDREN
Department of Health and Human Services
$2.7M
FUNCTIONAL IMAGING OF CORTICO-LIMBIC PREDICTORS OF EMOTION REGULATION, EMOTION REACTIVITY, AND RISK FOR SUICIDAL IDEATION AND BEHAVIOR
Department of Health and Human Services
$2.7M
AEROBIC EXERCISE FOR SMOKERS WITH DEPRESSIVE SYMPTOMATOLOGY
Department of Health and Human Services
$2.7M
EFFICACY OF A PRENATAL YOGA INTERVENTION FOR ANTENATAL DEPRESSION
Department of Health and Human Services
$2.7M
REDUCING STIS IN EMERGING ADULTS WHO USE ALCOHOL AND MARIJUANA
Department of Health and Human Services
$2.6M
EARLY LIFE STRESS: EPIGENETIC REGULATION OF ENDOCRINE AND IMMUNE PATHWAYS
Department of Health and Human Services
$2.6M
VARENICLINE VERSUS NICOTINE REPLACEMENT FOR METHADONE-MAINTAINED SMOKERS
Department of Health and Human Services
$2.6M
TRANSLATING COPD GUIDELINES INOT PRIMARY CARE PRACTICE
Department of Health and Human Services
$2.6M
CHILDHOOD MALTREATMENT:BIOMARKERS OF RISK AND RESILIENCE
Department of Health and Human Services
$2.5M
WHISH-2-PREVENT HEART FAILURE STUDY
Department of Health and Human Services
$2.5M
RESIDENCY TRAINING IN PRIMARY CARE
Department of Health and Human Services
$2.5M
AA LINKAGE FOR ALCOHOL ABUSING WOMEN LEAVING JAIL
Department of Health and Human Services
$2.4M
IMPROVING FUNCTIONING IN HIV PATIENTS WITH CHRONIC PAIN AND COMORBID DEPRESSIVE SYMPTOMS
Department of Health and Human Services
$2.4M
COMPARING BRIEF ALCOHOL INTERVENTIONS FOR HIV-HCV CO-INFECTED PERSONS
Department of Health and Human Services
$2.4M
LINKING OPIOID DEPENDENT PATIENTS FROM INPATIENT DETOXIFICATION TO PRIMARY CARE
Department of Health and Human Services
$2.3M
MULTI-METHOD ASSESSMENT OF EMOTION REACTIVITY: TRANSLATIONAL RESEARCH IN SUICIDE
Department of Health and Human Services
$2.2M
CONTROLLED TRIAL OF DBS FOR OCD
Department of Health and Human Services
$2.2M
RCT OF A TAILORED WALKING PROGRAM TO REDUCE STRESS AMONG PREGNANT WOMEN
Department of Health and Human Services
$1.9M
HEMODYNAMIC AND COGNITIVE FUNCTION IN CARDIOVASCULAR DISEASE
Department of Health and Human Services
$1.8M
TESTING THE EFFICACY OF AN EXERCISE INTERVENTION FOR PATIENTS WITH OCD
Department of Health and Human Services
$1.7M
LINKAGE OF HOSPITALIZED OPIOID USERS TO BUPRENORPHINE
Department of Health and Human Services
$1.7M
SEQUENTIAL USE OF FLUOXETINE FOR SMOKERS WITH ELEVATED DEPRESSIVE SYMPTOMS
Department of Health and Human Services
$1.6M
RCT OF HATHA YOGA FOR PERSISTENT DEPRESSION
Department of Health and Human Services
$1.5M
ACCOUNTABLE HEALTH COMMUNITIES TRACK 3
Department of Health and Human Services
$1.5M
BEHAVIORAL AND ECOLOGICAL SUICIDE TRACKING: ATTENTION, INTERPRETATION, AND MEMORY
Department of Health and Human Services
$1.5M
MI: EMPOWERING WOMEN TO MAKE CONTRACEPTIVE CHOICES WHILE INCARCERATED
Department of Health and Human Services
$1.3M
RESIDENCY TRAINING IN PRIMARY CARE
Department of Health and Human Services
$1.3M
DISTRESS TOLERANCE TREATMENT FOR SMOKING CESSATION
Department of Health and Human Services
$1.3M
SUSTAINING TOBACCO ABSTINENCE AFTER INCARCERATION
Department of Health and Human Services
$1.1M
PRIMARY CARE TRAINING AND ENHANCEMENT
Department of Health and Human Services
$1.1M
ETHNIC HEALTH/MOTIVATING HIV+ LATINOS TO QUIT SMOKING
Department of Health and Human Services
$922.8K
A COMPUTATIONAL ANALYSIS OF PSYCHIATRIC GENETICS DATA: PATHWAYS AND ARCHITECTURE
Department of Health and Human Services
$921.7K
DEVELOPMENT OF A BEHAVIORAL TEAM INTERVENTION FOR OBSESSIVE COMPULSIVE DISORDER
Department of Health and Human Services
$830.8K
TDCS TO DECREASE OPIOID RELAPSE
Department of Health and Human Services
$811K
OPTIMIZATION AND MULTI-SITE FEASIBILITY OF YOGA FOR CHRONIC PAIN IN PEOPLE IN TREATMENT FOR OPIOID USE DISORDER
Department of Health and Human Services
$791.7K
A TAILORED PHYSICAL ACTIVITY SMARTPHONE APP FOR PATIENTS WITH ALCOHOL DEPENDENCE
Department of Health and Human Services
$777.1K
DEVELOPMENT AND PRELIMINARY TESTING OF A PEER NARRATIVE VIDEO INTERVENTION FOR OLDER ADULTS WITH CHRONIC PAIN - CHRONIC MUSCULOSKELETAL (MSK) PAIN, WHICH INCLUDES SPINAL PAIN, OSTEOARTHRITIS, AND FIBROMYALGIA, IS A COMMON AND COSTLY PROBLEM FOR OLDER ADULTS AND IS ASSOCIATED WITH DECREASED QUALITY OF LIFE. THERE IS A CLEAR NEED FOR INTERVENTIONS THAT INCREASE ONE’S ABILITY TO COPE WITH CHRONIC PAIN AND ENGAGE IN MEANINGFUL LIFE ACTIVITIES EVEN WITH THE PRESENCE OF CHRONIC PAIN. ACCEPTANCE AND COMMITMENT THERAPY (ACT) IS A PSYCHOTHERAPY THAT USES MINDFULNESS AND PSYCHOLOGICAL ACCEPTANCE TO SUPPORT INDIVIDUALS IN WORKING TOWARD BEHAVIORAL GOALS GUIDED BY THEIR PERSONAL VALUES, EVEN IN THE PRESENCE OF UNDESIRABLE EXPERIENCES SUCH AS CHRONIC PAIN. CLINICAL PRACTICE GUIDELINES RECOMMEND THE USE OF ACT FOR TREATING CHRONIC PAIN BASED ON EVIDENCE OF EFFECTIVENESS FROM MULTIPLE RCTS. HOWEVER, UPTAKE AND REACH ARE LIMITED BECAUSE THERE ARE INSUFFICIENT NUMBERS OF MENTAL HEALTH PROFESSIONALS WHO CURRENTLY OFFER ACT OR OTHER RECOMMENDED THERAPIES (E.G., COGNITIVE-BEHAVIORAL THERAPY) FOR CHRONIC PAIN. IN ADDITION, MANY OLDER ADULTS ARE NOT WILLING OR ABLE TO ENGAGE IN TRADITIONAL PSYCHOTHERAPY FOR CHRONIC PAIN EVEN WHEN IT IS AVAILABLE. ALTHOUGH SOME BIBLIOTHERAPY AND DIGITAL HEALTH INTERVENTIONS (E.G., APPS) HAVE BEEN DEVELOPED FOR TREATING PAIN, MANY OLDER ADULTS FAIL TO USE THEM DUE TO LOW LEVELS OF COMFORT WITH TECHNOLOGY OR LACK OF MOTIVATION FOR INTENSIVE SELF-GUIDED APPROACHES. NARRATIVE COMMUNICATION IS AN ALTERNATIVE WAY TO DELIVER BEHAVIOR CHANGE PRINCIPLES THAT INVOLVES “STORYTELLING” INVOLVING REAL PATIENTS TALKING ABOUT THEIR STRUGGLES AND RECOVERY PROGRESS. THERAPEUTIC NARRATIVES DELIVERED VIA VIDEOS MAY BE MORE ENGAGING AND IMMERSIVE THAN TRADITIONAL SELF-HELP FORMATS FOR OLDER ADULTS. IN PREVIOUS GRANT-FUNDED RESEARCH, OUR TEAM HAS DEVELOPED METHODS FOR CREATING NARRATIVE, VIDEO-BASED INTERVENTIONS DESIGNED TO REDUCE DEPRESSION IN PRIMARY CARE PATIENTS AND PREVENT SUICIDE IN PATIENTS FOLLOWING A PSYCHIATRIC HOSPITAL. THUS, IN THIS PROJECT, WE PROPOSE TO CREATE RECLAIM YOUR DAY (RYD), WHICH WILL CONSIST OF 6, 30-MIN WEEKLY VIDEO EPISODES HIGHLIGHTING PATIENTS’ INSPIRING AND ILLUSTRATIVE EXPERIENCES LIVING WITH CHRONIC PAIN IN ORDER TO TEACH CURRENT PATIENTS WITH CHRONIC MSK PAIN HOW TO APPLY ACT’S EVIDENCE-BASED STRATEGIES. IN PHASE 1 OF THIS PROJECT, WE WILL INTERVIEW OLDER ADULTS WITH CHRONIC MSK PAIN ABOUT THEIR COPING HISTORY, AND CODE INTERVIEWS FOR CONSISTENCY WITH ACT PRINCIPLES. WE WILL INVITE A SUBSET OF THESE INDIVIDUALS TO WORK WITH A PROFESSIONAL STORYTELLING COACH TO DEVELOP AND VIDEORECORD THEIR ACT-CONSISTENT STORIES. THESE DOCUMENTARY-STYLE VIDEOS THAT WILL FORM THE BASIS OF RYD. IN PHASE 2, WE WILL CONDUCT A PILOT RCT (N=100) OF OLDER ADULTS WITH CHRONIC MSK PAIN. ALL PARTICIPANTS WILL RECEIVE A 30-MIN INTRODUCTORY PAIN EDUCATION VIDEO. PARTICIPANTS WILL BE RANDOMIZED TO RECEIVE EITHER RYD OR A COMPARISON INTERVENTION (HEALTH EDUCATION VIDEOS). WE WILL EXAMINE RYD FEASIBILITY AND ACCEPTABILITY AS WELL AS CHANGES OVER TIME IN OUTCOMES (PAIN INTERFERENCE, DEPRESSION, QUALITY OF LIFE) AND PUTATIVE MEDIATORS.
Department of Health and Human Services
$754.5K
PEER-FACILITATED PHYSICAL ACTIVITY INTERVENTION DELIVERED DURING METHADONE MAINTENANCE
Department of Health and Human Services
$738.1K
NEUROANATOMICAL CHANGES AFTER VENTRAL CAPSULOTOMY FOR INTRACTABLE OCD: A TRANSLAT
Department of Health and Human Services
$733.4K
TRANSLATING COPD GUIDELINES INOT PRIMARY CARE PRACTICE
Department of Health and Human Services
$727.9K
DEVELOPMENT OF A PSYCHOSOCIAL TREATMENT FOR PSYCHOTIC DEPRESSION
Department of Health and Human Services
$704K
MOBILE AFTER-CARE SUPPORT INTERVENTION FOR PATIENTS WITH SCHIZOPHRENIA FOLLOWING HOSPITALIZATION
Department of Health and Human Services
$686.2K
EXAMINING FEASIBILITY, ACCEPTABILITY, AND SUSTAINABILITY OF A NOVEL PERSONALIZED SMARTPHONE INTERVENTION FOR SUICIDE. - PROJECT SUMMARY/ABSTRACT SUICIDE IS A SERIOUS PUBLIC HEALTH CONCERN IN THE UNITED STATES. HOWEVER, DESPITE AN INCREASE IN THEORETICAL MODELS OF AND TREATMENTS FOR SUICIDE, THE SUICIDE RATE HAS RISEN 33% SINCE 1999. GIVEN THE WIDESPREAD AVAILABILITY OF SMARTPHONE TECHNOLOGY, THERE IS GREAT POTENTIAL TO DELIVER INTERVENTIONS VIA MOBILE PLATFORMS. HOWEVER, DESPITE THE PROLIFERATION OF SMARTPHONE TOOLS FOR SUICIDE, FEW OFFER EVIDENCE-BASED SUPPORT AND SOME INCLUDE POTENTIALLY HARMFUL CONTENT. IN RESPONSE, WE HAVE CONDUCTED INITIAL DEVELOPMENT OF A MOBILE SUICIDE PREVENTION SYSTEM: MOBILE APPLICATION TO PREVENT SUICIDE (MAPS). MAPS WAS SPECIFICALLY DESIGNED TO IDENTIFY INCREASED SUICIDE RISK AND DELIVER PERSONALIZED INTERVENTION FOR PATIENTS TRANSITIONING OUT OF A PSYCHIATRIC HOSPITAL, A TIME OF EXTRAORDINARILY HIGH RISK. MAPS PROVIDES BOTH A MOBILE APP AND CLINICIAN SUPPORT, AND INCLUDES MULTIPLE EVIDENCE-BASED COMPONENTS: (1) MONITORING OF THOUGHTS, EMOTIONS, AND BEHAVIORS VIA ECOLOGICAL MOMENTARY ASSESSMENT (EMA), (2) PERSONALIZED, INTERACTIVE COPING STRATEGY ADMINISTRATION BASED ON PARTICIPANTS’ CURRENT RISK STATE, (3) DIRECT ACCESS TO CLINICIANS AND CRISIS SUPPORT SERVICES, AND (4) PSYCHOEDUCATION. WE WILL LEVERAGE EXISTING COMPONENTS OF MAPS AND DEVELOP AND TEST NEW FEATURES. TO PLAN FOR SUSTAINABILITY OF MAPS, WE WILL DELIVER THE INTERVENTION THROUGH THE BUTLER HOSPITAL TRANSITIONAL OUTPATIENT PROGRAM, ASSIGNING PARTICIPANTS TO MASTER’S LEVEL HOSPITAL CLINICIANS, AND CONVENE A STAKEHOLDER ADVISORY BOARD WITH A FOCUS ON PROGRAM SUSTAINABILITY. SPECIFICALLY, THE PRIMARY AIM OF THIS INVESTIGATION IS TO ESTABLISH FEASIBILITY, ACCEPTABILITY, SAFETY, AND ESTIMATE KEY PARAMETERS FOR PRIMARY OUTCOMES (I.E., SUICIDAL IDEATION AND BEHAVIOR; RE-HOSPITALIZATION), AND TARGET MECHANISMS (I.E., SELF-MONITORING, USE OF COPING STRATEGIES, REDUCTION OF NEGATIVE AFFECT, SELF-EFFICACY). THE ULTIMATE GOAL OF THIS PROJECT IS TO FURTHER DEVELOP AND REFINE THE MAPS SYSTEM AND ENGAGE IN PRELIMINARY TESTING IN PREPARATION FOR A FULLY-POWERED RANDOMIZED CLINICAL TRIAL (R01) TO ESTABLISH EFFECTIVENESS OF THE INTERVENTION IN A LARGER HEALTH CARE SYSTEM AND TO FURTHER OPTIMIZE INTERVENTION COMPONENTS AND DELIVERY (E.G., MACHINE LEARNING TECHNIQUES). THIS PROPOSAL OUTLINES PROCEDURES FOR INTERVENTION AND CLINICIAN TRAINING PROGRAM REFINEMENT THROUGH FOCUS GROUPS AND OPEN AND RANDOMIZED PILOT TRIALS. THUS, THE PRESENT STUDY IS DESIGNED TO DEVELOP THE TOOLS, PROCEDURES, AND KNOWLEDGE BASE FOR A NOVEL INTERVENTION.
Department of Health and Human Services
$684.2K
BRIEF MINDFULNESS CESSATION TRAINING WITH EMA FOR POST-HOSPITAL DEPRESSED SMOKERS
Department of Health and Human Services
$676.3K
DEVELOPMENT OF AN ADJUNCTIVE VIDEO-BASED SUICIDE PREVENTION INTERVENTION IMMEDIATELY FOLLOWING PSYCHIATRIC HOSPITALIZATION
Department of Health and Human Services
$651.1K
EFFECTIVENESS OF PSYCHOSOCIAL TREATMENT FOR INPATIENTS WITH PSYCHOSIS
Department of Health and Human Services
$648.5K
COMPUTER-BASED MI TO ENGAGE SMOKERS LIVING WITH HIV IN TOBACCO QUITLINE TREATMENT
Department of Health and Human Services
$646.5K
DEVELOPMENT OF A TREATMENT ADHERENCE PROGRAM FOR BIPOLAR SUBSTANCE ABUSERS
Department of Health and Human Services
$645K
NARRATIVE INTERVENTION TO DISSEMINATE ACT FOR DEPRESSION IN PRIMARY CARE
Department of Health and Human Services
$642.8K
A TARGETED, REAL-TIME, TECHNOLOGY-SUPPORTED INTERVENTION FOR PATIENTS WITH ALCOHOL USE DISORDER ON DISULFIRAM
Department of Health and Human Services
$638.3K
PROJECT CHOICE: CHOOSING HEALTHY OPTIONS IN COPING WITH EMOTIONS, A PERSONALIZED-FEEDBACK EMA/EMI STUDY FOR EMERGING ADULTS LEAVING PSYCHIATRIC PARTIAL HOSPITALIZATION - ABSTRACT EMERGING ADULTHOOD REPRESENTS A COMMON TIME FOR PROBLEMATIC MENTAL HEALTH ISSUES, PARTICULARLY AFFECTIVE DISORDERS SUCH AS ANXIETY AND DEPRESSION, AND PROBLEMATIC PATTERNS OF ALCOHOL USE. HEAVY ALCOHOL USE CAN LEAD TO NEGATIVE MENTAL HEALTH, ACADEMIC, PHYSICAL HEALTH, AND COGNITIVE FUNCTIONING OUTCOMES. IN PARTICULAR, INDIVIDUALS WHO USE ALCOHOL ARE MORE LIKELY TO HAVE PSYCHIATRIC COMORBIDITY AND HAVE POORER CLINICAL OUTCOMES. COMORBIDITY IS ASSOCIATED WITH MORE RISK THAN PSYCHIATRIC SYMPTOMATOLOGY OR ALCOHOL USE ALONE, YET IS RARELY TARGETED IN MENTAL HEALTH SETTINGS. USING SUBSTANCES FOR THE MOTIVE OF COPING WITH NEGATIVE AFFECT COMPOUNDS RISKS, AS THOSE WHO USE TO COPE EXPERIENCE THE MOST PROBLEMS. AS SUCH, IT IS IMPORTANT TO TARGET ALCOHOL USE, PARTICULARLY IN EA WITH AFFECTIVE DISORDERS WHO USE TO COPE. TYPICAL TREATMENT FOR ALCOHOL IS BRIEF, MOTIVATIONALLY-BASED, AND PROVIDES NORMATIVE FEEDBACK. WE PROPOSE TO ENHANCE OUR EXISTING INTERVENTIONS WITH EA IN PSYCHIATRIC CARE WITH AFFECTIVE DISORDERS WHO USE ALCOHOL TO COPE, WHICH CAPITALIZED ON TECHNOLOGY. TECHNOLOGY ALLOWS FOR ASSESSMENT OF HIGH-RISK SITUATIONS IN REAL TIME THROUGH ECOLOGICAL MOMENTARY ASSESSMENT (EMA) AND DELIVERY OF INTERVENTIONAL CONTENT BY ECOLOGICAL MOMENTARY INTERVENTION (EMI). THE DELIVERY OF TAILORED, JUST-IN-TIME RISK REDUCTION MESSAGE PAIRED WITH PERSONALIZED NORMATIVE FEEDBACK MAY IMPACT PROBLEMATIC USE AND DEPRESSION/ANXIETY OUTCOMES BY REDUCING THE LIKELIHOOD OF USE AND NEGATIVE OUTCOMES OF USE. WE PROPOSE TO ENHANCE OUR EXISTING PILOT INTERVENTION BY INTEGRATING PARTICIPANT FEEDBACK AND PROTOCOL REFINEMENT. IN PHASE 1, WE WILL (1) MAKE CHANGES TO THE PILOT PFICOPE+EMI, BASED ON PARTICIPANT AND RESEARCHER EXPERIENCE; (2) EVALUATE THE REFINED INTERVENTION THROUGH A SERIES OF FOCUS GROUPS. IN PHASE 2, WE WILL TEST OUR REFINED INTERVENTION (PFICOPE+EMI) AND IN A RANDOMIZED, CONTROLLED TREATMENT TRIAL AS COMPARED TO PERSONALIZED NORMATIVE FEEDBACK ONLY, DELIVERED AT BASELINE (PNF). THE PFICOPE+EMI CONSISTS OF: 1) AN IN-PERSON PERSONALIZED FEEDBACK SESSION TO PRESENT NORMATIVE INFORMATION, DISCUSS THE INDIVIDUAL'S USE, AND GENERATE RISK REDUCTION MESSAGES TO BE USED IN EMI; 2) EMA TO MONITOR AFFECT, USE INTENTION, ACTUAL ALCOHOL USE, COPING MOTIVES, AND ALTERNATE COPING SKILLS UTILIZATION; AND 3) TAILORED MESSAGES (EMI) BASED ON EMA (I.E., NORMATIVE FEEDBACK PLUS INDIVIDUALIZED RISK REDUCTION MESSAGES WHEN INDIVIDUALS REPORT NEGATIVE AFFECT AND USE INTENTION). THE PNF CONDITION WILL RECEIVE 1) AN IN-PERSON PERSONALIZED FEEDBACK SESSION TO PRESENT NORMATIVE INFORMATION, DISCUSS THE INDIVIDUAL'S USE, DELIVERED AT BASELINE. WE ANTICIPATE THAT THIS PROJECT WILL LEAD TO THE DEVELOPMENT OF A WELL-SPECIFIED, NOVEL, TECHNOLOGY- SUPPORTED, REAL-TIME INTERVENTION FOR EA WITH COMORBID ALCOHOL AND DEPRESSION/ANXIETY THAT CAN BE LATER TESTED IN A MULTI-SITE FULLY-POWERED RCT.
Department of Health and Human Services
$627K
2/2 COLLABORATIVE STUDY: TESTOSTERONE AUGMENTATION IN WOMEN
Department of Health and Human Services
$620.1K
PSYCHOSOCIAL TREATMENT DEVELOPMENT FOR DEPRESSION WITH COMORBID CHRONIC PAIN
Department of Health and Human Services
$615.2K
YOGA TO TREAT CHRONIC PAIN IN PERSONS RECEIVING OPIOID AGONIST THERAPY
Department of Health and Human Services
$613.1K
ENGAGING HIV PATIENTS IN PRIMARY CARE BY PROMOTING ACCEPTANCE
Department of Health and Human Services
$600.5K
PHARMACOTHERAPY RELAPSE PREVENTION IN BDD
Department of Health and Human Services
$597.8K
DEVELOPMENT OF A HOME-BASED FAMILY TREATMENT FOR POSTPARTUM DEPRESSION
Department of Health and Human Services
$595.2K
NEUROIMAGING PREDICTORS OF RELAPSE DURING TREATMENT FOR OPIATE DEPENDENCE
Department of Health and Human Services
$587.2K
INSOMNIA AND DRUG RELAPSE RISK
Department of Health and Human Services
$583.7K
BRIEF COMPUTER INTERVENTION TO MOTIVATE QUITLINE USE FOR SMOKERS IN SUD TREATMENT
Department of Health and Human Services
$572.7K
TREATING CHRONIC PAIN IN BUPRENORPHINE PATIENTS IN PRIMARY CARE SETTINGS
Department of Health and Human Services
$569K
DEVELOPMENT OF A YOGA INTERVENTION FOR ANTENATAL DEPRESSION
Department of Health and Human Services
$555.4K
BEHAVIORAL EXERCISE INTERVENTION FOR SMOKING CESSATION
Department of Health and Human Services
$545.7K
DISTRESS TOLERANCE AND REDUCING EARLY RELAPSE IN BUPRENORPHINE PATIENTS
Department of Health and Human Services
$541.2K
ROUTINE HIV TESTING IN PRIMARY CARE PRACTICES
Department of Health and Human Services
$488K
COLORECTAL CANCER DECISION AIDS IN PRIMARY CARE
Department of Health and Human Services
$439.5K
DEVELOPMENT OF A FAMILY-BASED, POST-DEPLOYMENT INTERVENTION
Department of Health and Human Services
$434.9K
METHODS FOR UNDERSTANDING SENTINEL EVENTS
Department of Health and Human Services
$434.2K
EXAMINING HIGHLY PALATABLE FOOD CONSUMPTION UPON INITIATION OF METHADONE MAINTENANCE TREATMENT - ABSTRACT INCREASES IN OPIOID USE DISORDER (OUD) IN THE LAST DECADE HAS CREATED A PUBLIC HEALTH CRISIS. METHADONE MAINTENANCE TREATMENT (MMT) IS THE MOST COMMON TREATMENT FOR OUD. WHILE MMT IS EFFECTIVE IN HELPING PATIENTS IMPROVE THEIR QUALITY OF LIFE, PHYSICAL AND MENTAL HEALTH COMORBIDITIES ARE COMMON AND INCREASE RISK FOR PREMATURE DEATH. WHILE UNHEALTHY LIFESTYLE BEHAVIORS SUCH AS PHYSICAL INACTIVITY AND CIGARETTE SMOKING HAVE BEEN TARGETED, THE ROLE OF NUTRITIONAL INTAKE IN THIS POPULATION HAS BEEN RELATIVELY UNEXPLORED. CLINICALLY SIGNIFICANT INCREASES IN WEIGHT (AT LEAST 10%) HAVE BEEN CONSISTENTLY OBSERVED, AS WELL AS OFT-REPORTED CRAVINGS FOR SWEET FOODS UPON MMT INITIATION. MISSING FROM THE EXISTING LITERATURE IS A CLEAR UNDERSTANDING OF WHY THIS PHENOMENON OCCURS, LIMITING THE ABILITY TO EFFECTIVELY TARGET THIS PROBLEM WITH APPROPRIATE INTERVENTION. PURPORTED EXPLANATIONS FOR WEIGHT GAIN HAVE INCLUDED INCREASED FOOD INTAKE TO COMPENSATE FOR UNDERNOURISHMENT DURING THE TIME OF ACTIVE ILLICIT OPIOID USE AND THE PHARMACOLOGICAL EFFECTS OF METHADONE ON PANCREATIC CELL DYSFUNCTION AND SWEET TASTE PREFERENCE. HOWEVER, THESE POSSIBILITIES MAY ONLY PARTIALLY EXPLAIN WEIGHT GAIN AS MOST PATIENTS STARTING TREATMENT ARE ALREADY OVERWEIGHT OR OBESE AND INCREASES IN WEIGHT CONTINUE EVEN WHEN METHADONE DOSES ARE STABLE. WE ARE PROPOSING AN ADDITIONAL HYPOTHESIS: PATIENTS STARTING MMT WILL CONSUME FOODS THAT ARE HIGHLY PALATABLE (HPF; I.E., HIGH IN FAT, SUGAR, OR BOTH) IN AN EFFORT TO MANAGE NEGATIVE AFFECT AND OPIOID CRAVINGS THAT ARE COMMON DURING EARLY RECOVERY. ANECDOTAL REPORTS OF PATIENTS IN SUBSTANCE USE TREATMENT PROVIDE SUPPORT FOR THIS HYPOTHESIS – HPF PROVIDE EMOTIONAL RELIEF AND DECREASE DRUG CRAVINGS. AN EMERGING BODY OF BASIC SCIENCE LITERATURE DEMONSTRATES SHARED NEURAL MECHANISMS OF BOTH HPF AND DRUGS OF ABUSE. AS WITH DRUGS, HPF POTENTIATES ENDOGENOUS OPIOID AND DOPAMINE RELEASE IN THE NUCLEUS ACCUMBENS, WHICH, THROUGH REPEATED OVERCONSUMPTION, CAN ALSO LEAD TO DISRUPTED REWARD PATHWAYS. INDEED, IN NON-SUBSTANCE USING POPULATIONS, OVERCONSUMPTION OF HPF CAN LEAD TO POORER PSYCHOLOGICAL FUNCTIONING SUCH AS DEPRESSION AND ANXIETY (KNOWN RELAPSE RISKS IN THOSE WITH OUD). THEREFORE, WHILE HPF MAY HAVE A SHORT-TERM BENEFICIAL EFFECT ON IMPROVING NEGATIVE AFFECT AND DECREASING OPIOID CRAVINGS AMONG PATIENTS IN MMT, IT MAY ALSO CONFER A LONGER-TERM RISK FOR RELAPSE IN THIS POPULATION. UNDERSTANDING THE WITHIN-PERSON ASSOCIATIONS BETWEEN NEGATIVE AFFECT, OPIOID CRAVINGS, AND CONSUMPTION OF HPF AT THE DAILY LEVEL AND OVER THE COURSE OF EARLY MMT INITIATION IS CRITICAL FOR INFORMING THE DEVELOPMENT OF ADJUNCTIVE, NUTRITION-FOCUSED INTERVENTIONS IN THIS AT-RISK POPULATION. WE PROPOSE TO CONDUCT A 26-WEEK PROSPECTIVE STUDY OF 80 PATIENTS WHO RECENTLY INITIATED MMT UTILIZING ECOLOGICAL MOMENTARY ASSESSMENT (EMA; THROUGH THREE, 21-DAY BOUTS). IN DOING SO, WE CAN ANSWER THE QUESTION OF WHETHER HPF CONSUMPTION DURING EARLY MMT IS BENEFICIAL OR DETRIMENTAL TO RISK FOR RETURNING TO ILLICIT OPIOID USE. WITH THIS INFORMATION, MORE EFFECTIVE INTERVENTIONS COULD BE DEVELOPED TO EXTEND RECOVERY AND DECREASE THE PUBLIC HEALTH IMPACT OF OUD.
Department of Health and Human Services
$421.7K
DEVELOPMENT OF AN INTERVENTION FOR SUICIDE ATTEMPTERS
Department of Health and Human Services
$420.2K
TECHNOLOGY-ASSISTED ASSESSMENT OF POST-HOSPITAL ADHERENCE IN SCHIZOPHRENIA
Department of Health and Human Services
$407.4K
DISCONTINUATION OF LONG-TERM SRIS IN OBSESSIVE COMPULSIVE DISORDER
Department of Health and Human Services
$404.9K
A SMARTPHONE APP TO FACILITATE BUPRENORPHINE DISCONTINUATION
Department of Health and Human Services
$397.7K
A TAILORED PHYSICAL ACTIVITY SMARTPHONE APP FOR PATIENTS WITH ALCOHOL DEPENDENCE
Department of Health and Human Services
$395.4K
TREATMENT-SEEKING FOR DEPRESSION AMONG PREGNANT WOMEN
Department of Health and Human Services
$395.1K
A MACHINE LEARNING APPROACH FOR INFERRING ALCOHOL INTOXICATION LEVELS FROM GAIT DATA
Department of Health and Human Services
$388.7K
CHILDHOOD MALTREATMENT: EPIGENETIC MODULATION OF THE GLUCOCORTICOID RECEPTOR
Department of Health and Human Services
$384.1K
BEHAVIORAL CONSULTATION FOR HIV+ OLDER ADULTS PRESCRIBED OPIOIDS FOR CHRONIC PAIN
Department of Health and Human Services
$382.6K
TREATING CHRONIC PAIN AND DEPRESSION IN HIV PATIENTS IN PRIMARY CARE SETTINGS
Department of Health and Human Services
$378.9K
DEVELOPMENT OF TAILORED INTERVENTION TO PROMOTE CRC SCREENING AMONG LATINO MEN
Department of Health and Human Services
$375.9K
COVID19 VACCINE HESITANCY AMONG PERINATAL WOMEN AT RISK FOR HEALTH DISPARITIES - ABSTRACT DESPITE SAFETY DATA SUPPORTING USE OF COVID-19 VACCINES AMONG PREGNANT AND LACTATING WOMEN, COVID-19 VACCINE COVERAGE AMONG PERINATAL WOMEN IN THE UNITED STATES IS VERY LOW, WITH UPTAKE EVEN LOWER AMONG SOME RACIAL AND ETHNIC GROUPS SUCH AS BLACK/AFRICAN AMERICAN AND LATINA WOMEN. CONCERNINGLY, PREGNANCY IS ASSOCIATED WITH MORE SEVERE OUTCOMES ASSOCIATED WITH COVID-19 INFECTION: PREGNANT WOMEN WITH COVID-19 HAVE HIGHER RATES OF ICU ADMISSION, MECHANICAL VENTILATION, AND MORTALITY COMPARED TO WOMEN WITH COVID-19 WHO ARE NOT PREGNANT. FURTHER, INFANTS BORN TO WOMEN WITH COVID-19 ARE MORE LIKELY TO BE BORN PRETERM, POTENTIALLY LEADING TO NUMEROUS DOWNSTREAM NEGATIVE CONSEQUENCES FOR THE CHILD’S HEALTH AND DEVELOPMENT. IN SPITE OF THE HIGH STAKES OF INFECTION FOR WOMEN AND THEIR OFFSPRING, LITTLE IS KNOWN ABOUT FACTORS CONTRIBUTING TO COVID-19 VACCINE HESITANCY (VH) AND REFUSAL AMONG PERINATAL WOMEN, PARTICULARLY THOSE AT HIGHEST RISK FOR HEALTH DISPARITIES. IDENTIFYING FACTORS CONTRIBUTING TO VH AMONG THIS VULNERABLE GROUP OF WOMEN IS CRUCIAL TO THE DEVELOPMENT OF EFFECTIVE INTERVENTIONS TO PROMOTE VACCINE UPTAKE. FURTHER, LITTLE IS KNOWN ABOUT FACTORS RELATING TO PRENATAL CARE PROVIDER BEHAVIOR AND RECOMMENDATIONS REGARDING COVID-19 VACCINATION DURING PREGNANCY AND POSTPARTUM. OUR EXPERIENCED, INTERDISCIPLINARY TEAM PROPOSES A 2-YEAR, MIXED METHODS R21 INVESTIGATION THAT INCLUDES BOTH A PATIENT COMPONENT AND A PROVIDER COMPONENT IN ORDER TO IDENTIFY KEY FACTORS CONTRIBUTING TO COVID-19 VACCINE UPTAKE AND REFUSAL IN THE PERINATAL PERIOD. IN THE PATIENT COMPONENT, WE WILL RECRUIT 120 ENGLISH AND SPANISH-SPEAKING FINANCIALLY-DISADVANTAGED PREGNANT AND POSTPARTUM WOMEN, INCLUDING HALF WHO WERE VACCINATED IN PREGNANCY AND HALF WHO ARE UNVACCINATED. GUIDED BY THE THEORY OF PLANNED BEHAVIOR AND THE FIVE C’S MODEL OF VACCINE HESITANCY, AND WITH INPUT FROM A DIVERSE GROUP OF COMMUNITY STAKEHOLDERS, WE WILL ASSESS COGNITIVE AND AFFECTIVE FACTORS, PSYCHOLOGICAL SYMPTOMS, MEDICAL MISTRUST, AND OTHER CONTRIBUTORS TO VACCINE DECISION-MAKING. WE WILL CONDUCT QUALITATIVE INTERVIEWS WITH A SUBSET OF WOMEN (N=30) TO AUGMENT OUR UNDERSTANDING OF FACTORS DRIVING VACCINE RELUCTANCE AND REFUSAL. IN THE PROVIDER COMPONENT, WE WILL RECRUIT 60 PRENATAL CARE PROVIDERS WHO WORK WITH FINANCIALLY DISADVANTAGED WOMEN (OBS, FAMILY MEDICINE, MIDWIVES, NURSES) TO TAKE PART IN AN IN-DEPTH SURVEY REGARDING FACTORS CONTRIBUTING TO VH, REFUSAL AND UPTAKE DURING THE PERINATAL PERIOD; A SUBSET OF 30 PROVIDERS WILL TAKE PART IN QUALITATIVE INTERVIEWS TO EXPLORE THESE ISSUES FURTHER. OUR ANALYTIC PLAN INVOLVES GENERALIZED LINEAR MODELS TO EXAMINE PREDICTORS OF PATIENT VACCINATION OUTCOMES, AND QUALITATIVE THEMATIC ANALYSIS TO IDENTIFY KEY THEMES WOMEN AND PROVIDERS ENDORSE REGARDING COVID-19 VACCINE HESITANCY. FINDINGS WILL INFORM PROVIDER EDUCATION AND SERVICES INNOVATIONS, AS WELL AS INTERVENTION DEVELOPMENT TO TARGET INCREASED VACCINATION UPTAKE THIS VULNERABLE PATIENT GROUP.
Department of Health and Human Services
$375.5K
TDCS FOR INHIBITORY CONTROL DEFICITS: A TEST IN OCD
Department of Health and Human Services
$369K
RESIDENCY TRAINING IN PRIMARY CARE
Department of Health and Human Services
$351K
MID-CAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE - RESEARCH
Department of Health and Human Services
$340.4K
TDCS FOR INCREASING EXERCISE ADHERENCE IN INDIVIDUALS WITH ELEVATED DEPRESSIVE SYMPTOMS
Department of Health and Human Services
$337.5K
A BRIEF MARIJUANA INTERVENTION FOR ADOLESCENT WOMEN
Department of Health and Human Services
$331.7K
MARIJUANA AND SLEEP IN YOUNG ADULTS
Department of Health and Human Services
$323K
PEER-FACILITATED PHYSICAL ACTIVITY INTERVENTION DELIVERED DURING METHADONE MAINTENANCE
Department of Health and Human Services
$317.7K
TREATMENT OF SUICIDE IN ALCOHOLIC AND DEPRESSED PATIENTS
Department of Health and Human Services
$317.1K
ANTIDEPRESSANTS DURING OFFICE-BASED BUPRENORPHINE
Department of Health and Human Services
$298.6K
LEAD EXPOSURE AND EARLY BRAIN DEVELOPMENT
Department of Health and Human Services
$297.6K
EHEALTH BP CONTROL PROGRAM
Department of Health and Human Services
$276.9K
ARRA - EQUIPMENT TO ENHANCE TRAINING FOR HEALTH PROFESSIONALS
Department of Health and Human Services
$250K
PRIMARY CARE TRAINING AND ENHANCEMENT
Department of Health and Human Services
$198K
HEALTH CARE AND OTHER FACILITIES
Department of Health and Human Services
$195.3K
DOUBLE-BLIND STUDY OF SAME VS ESCITALOPRAM IN MDD
Department of Health and Human Services
$194.8K
INITIATING AND MAINTAINING PHYSICAL ACTIVITY IN DEPRESSED INDIVIDUALS
Department of Health and Human Services
$181.1K
PSYCHOTHERAPY FOR DEPRESSED PRIMARY CARE PATIENTS
Department of Health and Human Services
$131.2K
PEER GROUP NETWORKS AND ADOLESCENT SMOKING
Department of Health and Human Services
$107.9K
A CLIMATE FOR EVIDENCE-BASED PRACTICE IMPLEMENTATION IN THE PATIENT-CENTERED MEDICAL HOME
Department of Health and Human Services
$103.4K
THE DEVELOPMENT OF AN IMPLICIT MEASURE OF NON-JUDGMENT OF INTERNAL EXPERIENCES
Department of Health and Human Services
$89.6K
BARRIERS TO ENTRY INTO COUPLES' TREATMENT OF PROBLEMATIC ALCOHOL USE
Department of Health and Human Services
$51.6K
INTEGRATED PRIMARY CARE FOR MEDICALLY UNEXPLAINED SYMPTOMS
Department of Health and Human Services
$45K
TRAINING CED/COR PEDIATRIC AND CHILD PSYCHIATRY
Department of Defense
-$3,584
BIOMARKERS OF RISK FOR POST-TRAUMATIC STRESS DISORDER
Source: Federal Audit Clearinghouse (fac.gov)
Years audited
9
Clean years
9
Material Weakness
No
Noncompliance Issues
No
| Year | Status | Financial Report | Federal Expenditurecombined across all audits filed that year | Low Risk | Accepted |
|---|---|---|---|---|---|
| 2025 | Clean | Unmodified (Clean) | $42.9M | Yes | 2025-12-19 |
| 2024 | Clean | Unmodified (Clean) | $54.9M | Yes | 2024-12-23 |
| 2023 | Clean | Unmodified (Clean) | $60.8M | Yes | 2024-01-03 |
| 2022 | Clean | Unmodified (Clean) | $82.8M | Yes | 2023-03-06 |
| 2021 | Clean | Unmodified (Clean) | $70.3M | Yes | 2022-06-22 |
| 2020 | Clean | Unmodified (Clean) | $117.5M | Yes | 2021-12-12 |
| 2019 | Clean | Unmodified (Clean) | $42.1M | Yes | 2020-06-17 |
| 2018 | Clean | Unmodified (Clean) | $31M | Yes | 2018-12-20 |
| 2016 | Clean | Unmodified (Clean) | $22.7M | Yes | 2017-06-07 |
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$42.9M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$54.9M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$60.8M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$82.8M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$70.3M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$117.5M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$42.1M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$31M
Financial Report
Unmodified (Clean)
Federal Expenditure, combined across all audits filed that year
$22.7M
Tax Year 2024 · Source: IRS e-Filed Form 990Schedule J available
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: SOUNK
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023IRS e-File | $186.6M | $130K | $194.3M | $67.1M | -$208.7M |
| 2022IRS e-File | $189.3M | $134.1K | $179.1M | $54.1M | -$197.7M |
| 2021 | $172M | $371.1K | $177.8M | $77.1M | -$204.4M |
| 2020 | $165.9M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
Financial data: IRS e-Filed Form 990 (Tax Year 2023)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Michael E Wagner Md | Director - President/ceo/cne | 55 | $1.7M | $0 | $32.6K | $1.7M |
| Todd A Conklin | Asst. Treas./evp/cfo/cne | 55 | $707.2K | $0 | $26.7K | $733.9K |
| Ashley M Taylor Esq | Asst. Sec./gen. Counsel/cne | 55 | $542.3K | $0 | $17.5K | $559.8K |
| Gary E Furtado | Chairman - Director | 1 | $0 | $0 | $0 | $0 |
| R Stephen Manty | Vice Chair/treasurer-director | 1 | $0 | $0 | $0 | $0 |
| James A Botvin | Secretary - Director | 1 | $0 | $0 | $0 | $0 |
Michael E Wagner Md
Director - President/ceo/cne
$1.7M
Hrs/Wk
55
Compensation
$1.7M
Related Orgs
$0
Other
$32.6K
Todd A Conklin
Asst. Treas./evp/cfo/cne
$733.9K
Hrs/Wk
55
Compensation
$707.2K
Related Orgs
$0
Other
$26.7K
Ashley M Taylor Esq
Asst. Sec./gen. Counsel/cne
$559.8K
Hrs/Wk
55
Compensation
$542.3K
Related Orgs
$0
Other
$17.5K
Gary E Furtado
Chairman - Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
R Stephen Manty
Vice Chair/treasurer-director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
James A Botvin
Secretary - Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Highest compensated employees who are not officers or directors.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Raymond O Powrie Md | Chief Medical Quality Officer | 55 | $0 | $741.9K | $33.2K | $775.1K |
| Gail E Robbins | Svp, Finance And Planning | 55 | $579.8K | $0 | $34K | $613.8K |
| Roger Mitty | President - Cnemg | 55 | $478.5K | $0 |
Raymond O Powrie Md
Chief Medical Quality Officer
$775.1K
Hrs/Wk
55
Compensation
$0
Related Orgs
$741.9K
Other
$33.2K
Gail E Robbins
Svp, Finance And Planning
$613.8K
Hrs/Wk
55
Compensation
$579.8K
Related Orgs
$0
Other
$34K
Roger Mitty
President - Cnemg
$479.2K
Hrs/Wk
55
Compensation
$478.5K
Related Orgs
$0
Other
$651
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Ana Tuya Fulton Md | Dir-chief Pop Hlth Off/cne | 55 | $590.9K | $0 | $21.2K | $612.1K |
| Carolyn Masters Phd Rn | Director | 1 | $0 | $0 | $0 | $0 |
| Charles R Reppucci Esq | Director | 1 | $0 | $0 | $0 | $0 |
| Joseph J Mcgair Esq | Director | 1 | $0 | $0 | $0 | $0 |
| Judith Remondi | Director |
Ana Tuya Fulton Md
Dir-chief Pop Hlth Off/cne
$612.1K
Hrs/Wk
55
Compensation
$590.9K
Related Orgs
$0
Other
$21.2K
Carolyn Masters Phd Rn
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Charles R Reppucci Esq
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Individuals who previously served as officers or key employees.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| James E Fanale Md | Former Officer | — | $1.3M | $0 | $140K | $1.5M |
| F Joseph Iannoni | Former Officer | — | $806.9K | $0 | $83.9K | $890.8K |
| Arnold Avila | Former Key Employee | — | $438.1K | $0 | $19K |
James E Fanale Md
Former Officer
$1.5M
Hrs/Wk
—
Compensation
$1.3M
Related Orgs
$0
Other
$140K
F Joseph Iannoni
Former Officer
$890.8K
Hrs/Wk
—
Compensation
$806.9K
Related Orgs
$0
Other
$83.9K
Arnold Avila
Former Key Employee
$457.1K
Hrs/Wk
—
Compensation
$438.1K
Related Orgs
$0
Other
$19K
| $556.4K |
| $165.7M |
| $107.2M |
| -$207.2M |
| 2019 | $151.8M | $1.1M | $151M | $96.3M | -$195.3M |
| 2018 | $148.6M | $962.4K | $154.5M | $111.2M | -$171.5M |
| 2017 | $145.4M | $249.7K | $158.3M | $130.8M | -$99M |
| 2016 | $138.3M | $0 | $190.9M | $155.5M | -$86.7M |
| 2015 | $127.6M | $0 | $132.1M | $187.5M | -$26.2M |
| 2014 | $115.1M | $0 | $116.9M | $194.1M | -$16.2M |
| 2013 | $94.6M | $3,465 | $92.6M | $139.7M | -$10.5M |
| 2012 | $87.1M | $0 | $87.3M | $152.8M | -$19.3M |
| 2011 | $57.8M | $100K | $57.9M | $129.2M | -$14.5M |
| 2021 | 990 | Data |
| 2020 | 990 | Data | PDF not yet published by IRS |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |
| $651 |
| $479.2K |
| Jessica Mccarthy | Vp, Chief Marketing Officer | 55 | $414.7K | $0 | $40.9K | $455.6K |
| Bryan Liese | Svp, Operations - Cnemg | 55 | $377.4K | $0 | $30.2K | $407.7K |
| Stephen M Silva | VP Logistic & Supply Chain | 55 | $365K | $0 | $32.3K | $397.3K |
| Krysten Blanchette | VP Rev Cycle | 55 | $360.1K | $0 | $35.3K | $395.4K |
| Mark Yerrick | VP Facilities & Support Svcs. | 55 | $372.3K | $0 | $22.7K | $395K |
| Jennie Henriques | Chief Compliance Officer | 55 | $372K | $0 | $16.5K | $388.5K |
| James M Burke | VP Finance Med/surg Hosp | 55 | $358.1K | $0 | $20.5K | $378.6K |
| Gary Speciale | VP Risk Management | 55 | $316K | $0 | $36.7K | $352.7K |
| Mae Medeiros | VP Laboratory Services | 55 | $0 | $282.1K | $44.9K | $327K |
| Dean R Carlson | VP Human Resources | 55 | $197.3K | $0 | $43.7K | $241.1K |
Jessica Mccarthy
Vp, Chief Marketing Officer
$455.6K
Hrs/Wk
55
Compensation
$414.7K
Related Orgs
$0
Other
$40.9K
Bryan Liese
Svp, Operations - Cnemg
$407.7K
Hrs/Wk
55
Compensation
$377.4K
Related Orgs
$0
Other
$30.2K
Stephen M Silva
VP Logistic & Supply Chain
$397.3K
Hrs/Wk
55
Compensation
$365K
Related Orgs
$0
Other
$32.3K
Krysten Blanchette
VP Rev Cycle
$395.4K
Hrs/Wk
55
Compensation
$360.1K
Related Orgs
$0
Other
$35.3K
Mark Yerrick
VP Facilities & Support Svcs.
$395K
Hrs/Wk
55
Compensation
$372.3K
Related Orgs
$0
Other
$22.7K
Jennie Henriques
Chief Compliance Officer
$388.5K
Hrs/Wk
55
Compensation
$372K
Related Orgs
$0
Other
$16.5K
James M Burke
VP Finance Med/surg Hosp
$378.6K
Hrs/Wk
55
Compensation
$358.1K
Related Orgs
$0
Other
$20.5K
Gary Speciale
VP Risk Management
$352.7K
Hrs/Wk
55
Compensation
$316K
Related Orgs
$0
Other
$36.7K
Mae Medeiros
VP Laboratory Services
$327K
Hrs/Wk
55
Compensation
$0
Related Orgs
$282.1K
Other
$44.9K
Dean R Carlson
VP Human Resources
$241.1K
Hrs/Wk
55
Compensation
$197.3K
Related Orgs
$0
Other
$43.7K
| 1 |
| $0 |
| $0 |
| $0 |
| $0 |
| Kevin Baill Md | Director - Med Dir Op Svcs/bh | 55 | $0 | $582.8K | $52.5K | $635.3K |
| Maribeth Q Williamson | Director | 1 | $0 | $0 | $0 | $0 |
| Patrick J Murray Jr | Director | 1 | $0 | $0 | $0 | $0 |
| Peter Philips | Director | 1 | $0 | $0 | $0 | $0 |
| Sharon Conard-Wells | Director | 1 | $0 | $0 | $0 | $0 |
Joseph J Mcgair Esq
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Judith Remondi
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Kevin Baill Md
Director - Med Dir Op Svcs/bh
$635.3K
Hrs/Wk
55
Compensation
$0
Related Orgs
$582.8K
Other
$52.5K
Maribeth Q Williamson
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Patrick J Murray Jr
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Peter Philips
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Sharon Conard-Wells
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
| $457.1K |
| John S Minichiello | Former Key Employee | — | $277.2K | $0 | $21.7K | $298.9K |
| Susan C Martin | Former Key Employee | — | $138K | $0 | $29.3K | $167.4K |
| John Polanowicz | Former Officer | — | $136.9K | $0 | $5,613 | $142.5K |
John S Minichiello
Former Key Employee
$298.9K
Hrs/Wk
—
Compensation
$277.2K
Related Orgs
$0
Other
$21.7K
Susan C Martin
Former Key Employee
$167.4K
Hrs/Wk
—
Compensation
$138K
Related Orgs
$0
Other
$29.3K
John Polanowicz
Former Officer
$142.5K
Hrs/Wk
—
Compensation
$136.9K
Related Orgs
$0
Other
$5,613